Founders / Sally Daub
Altis Labs
AI endpoints for oncology trials; IPRO model predicts survival from routine radiology scans (Nota platform).
- Role
- Co-founder/President
- HQ
- Toronto, ON
- Founded
- 2019
- Status
- Active
- Disclosed raised
- US$31M
- Latest round
- Series A, Sep 17, 2026
Co-founders: Felix Baldauf-Lenschen
Investors: OrbiMed, Qiming Venture Partners USA, Benchstrength, Debiopharm Innovation Fund, Innovation Endeavors, Fusion Fund, Lumira Ventures
In the newsletter
Founders are listed as named in primary coverage of their companies. Profile links are matched to the company before they are published. To correct this page or ask for it to be removed, email the Index.
Data as of September 29, 2026.